Profile
SPRO VRTX REGN VRNA ARGX ALNY
Company Name Spero Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $120.57M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.03K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Esther Rajavelu Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SPRO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
SPRO VRTX REGN VRNA ARGX ALNY
Last Close $2.43 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.04 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.56 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -20.07 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 333.93 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SPRO VRTX REGN VRNA ARGX ALNY
1 Month Return 9.95 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 27.23 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 273.27 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 195.94 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 135.92 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 109.48 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SPRO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SPRO VRTX REGN VRNA ARGX ALNY
Asset Growth -39.39 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -193.2 % 1.16 % - 26.81 %
Revenue Growth -53.77 % 0.99 % - 22.97 %
Revenue 3 Year 793.5 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -11.15 % 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -370.59 % 9.09 % -131.37 % 24.59 %
Net Income Growth -400.65 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 56.32 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 62.18 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 17.47 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -441.52 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 28.95 % - -143.33 % -107.98 %
Operating 3 Year CFG 79.17 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 84.25 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 70.18 % -100 % 40.15 % 97.08 %
EPS Growth -395.35 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -395.35 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -57.92 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -70.13 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -79.21 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 2776.23 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share -100 % - - -
Debt Growth -22.48 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 28.95 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SPRO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -202.62 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -80.92 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -125.91 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -115.54 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.67 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 93.02 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -130.89 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -825.84 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 14.55 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 77.59 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 2111.45 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 66.03 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.49 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.49 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 86.38 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -77.37 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -825.84 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -4.36 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -4.35 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -4.35 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
SPRO VRTX REGN VRNA ARGX ALNY
Revenue $0.05B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0.05B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio -101.67% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.07B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.07B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.27 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SPRO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.06B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.05B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.11B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SPRO VRTX REGN VRNA ARGX ALNY
Net Income $-0.07B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.77
AARD Aardvark Therapeutics, Inc. Common Stock 12.61
ABCL AbCellera Biologics Inc. 3.17
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.115
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.475
ABPWW 0.0131
ABSI Absci Corporation 2.65
ABUS Arbutus Biopharma Corporation 4.175
ABVC ABVC BioPharma, Inc. 1.7
ABVX Abivax SA American Depositary Shares 119.315
ACAD ACADIA Pharmaceuticals Inc. 22.7
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.13
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.35
ACIU AC Immune SA 3.035
ETFs With Exposure to SPRO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00014 341.86
IBB iShares Biotechnology ETF 0.01 172.16
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00011 151.53
VHT Vanguard Health Care Index Fund 0 287.45
BIB ProShares Ultra Nasdaq Biotechnology 0 84.575
VXF Vanguard Extended Market Index Fund 0.00144 219.39
IWC iShares Micro-Cap ETF 0.03097 169.93
VUN.TO Vanguard U.S. Total Market Index ETF 0.00014 125.89
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00014 118.65
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 115.43
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00017 115.41
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00007 52.63
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00007 52.62
VBINX Vanguard Balanced Index Fund Investor Shares 0.00007 52.62
VGRO.TO Vanguard Growth ETF Portfolio 0.00005 44.3
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00006 55.73
VBAL.TO Vanguard Balanced ETF Portfolio 0.00004 37.805
VCNS.TO Vanguard Conservative ETF Portfolio 0.00003 32.08
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.325
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00001 26.945
DFAU Dimensional US Core Equity Market ETF 0 48.015
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 29.34
DFAS Dimensional U.S. Small Cap ETF 0.00028249 76.31
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002791 41.32
VTSAX Vanguard Total Stock Market Index Fund 0.00014 166.85
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 8.67
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00144 166.55
VITSX Vanguard Total Stock Market Index Fund 0.00014 166.88
QQQS Invesco NASDAQ Future Gen 200 ETF 0.482286 35.725
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000173701 16.75
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00144 166.56
VEXPX Vanguard Explorer Fd 0 121.72
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 144.59
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 65.22
DFQTX DFA U.S. Core Equity 2 Portfolio 0 46.4
VTS.AX Vanguard US Total Market Shares Index ETF 0.00014 484.72
VEMPX Vanguard Extended Market Index InstlPlus 0.00144 411.02
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00014 313.05
AGGS Harbor ETF Trust 0.338388 41.4
Unlock